跳转至内容
Merck
CN

主要文件

查看所有文档

448877

壳聚糖

medium molecular weight

别名:

聚（D-氨基葡萄糖）, 脱乙酰几丁质

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

化学文摘社编号:
9012-76-4
UNSPSC Code:
12352201
NACRES:
NA.23
MDL number:
MFCD00161512
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

200

form

powder

viscosity

200-800 cP, 1 wt. % in 1% acetic acid(25 °C, Brookfield)(lit.)

solubility

dilute aqueous acid: soluble

storage temp.

2-30°C

SMILES string

N([C@H]1[C@@H](O[C@@H]([C@H]([C@@H]1O)O[C@@H]4O[C@@H]([C@H]([C@@H]([C@H]4N)O)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5N)O)O[C@@H]6O[C@@H]([C@H]([C@@H]([C@H]6N)O)O[C@@H]7O[C@@H]([C@H]([C@@H]([C@H]7N)O)O[C@@H]8O[C@@H]([C@H]([C@@H]([C@H]8N)O)O[C@@H]9O[C@@H]([C@H](

InChI

1S/C56H103N9O39/c1-87-56(86)65-28-38(84)46(19(10-74)96-55(28)104-45-18(9-73)95-49(27(64)37(45)83)97-39-12(3-67)88-47(85)20(57)31(39)77)103-54-26(63)36(82)44(17(8-72)94-54)102-53-25(62)35(81)43(16(7-71)93-53)101-52-24(61)34(80)42(15(6-70)92-52)100-51-23(60)33(79)41(14(5-69)91-51)99-50-22(59)32(78)40(13(4-68)90-50)98-48-21(58)30(76)29(75)11(2-66)89-48/h11-55,66-85H,2-10,57-64H2,1H3,(H,65,86)/t11-,12-,13-,14-,15-,16-,17-,18-,19-,20-,21-,22-,23-,24-,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48+,49+,50+,51+,52+,53+,54+,55+/m1/s1

InChI key

FLASNYPZGWUPSU-SICDJOISSA-N

Application

与多价阴离子形成凝胶。 产生透明溶液，干燥后形成坚固、透明的薄膜。
壳聚糖可用作絮凝剂、蛋白质沉淀剂、包封剂和水增稠剂。

Features and Benefits

生物相容、抗菌和环保的聚电解质，其具有多种应用，包括水处理、色谱法、化妆品添加剂、抗微生物活性的纺织品处理、纺织品的新型纤维、照相纸、可生物降解的薄膜、生物医学装置、以及用于药物递送中控制释放的微胶囊植入物。
生物相容性、抗菌和环保的聚电解质。

Physical form

75-85% 脱乙酰化

Still not finding the right product?

Explore all of our products under 壳聚糖

存储类别

11 - Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
0000149455
BCCG6391
BCCG2332
BCCG4737
0000122569

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

用于细胞递送和组织再生的可注射水凝胶

将基于水凝胶的生物材料用于递送和募集细胞以促进体内组织再生是新生的研究热题。本文讨论了水凝胶在细胞递送和组织再生中的应用。

Chitosan in Pharmaceutical Applications

Polymers, natural or synthetic, are vital in medical advancements, contributing to device and pharmaceutical development in therapy.

Preparation of Chitosan Microparticles by Spray Drying

Carcinogenic compounds in elastomers: 1,3-butadiene and isoprene used in elastomer manufacturing, classified as carcinogenic by IARC.

查看所有文章
Enni Hakkarainen et al.
Pharmaceutics, 11(10) (2019-09-29)
We investigated nozzleless ultrasound-enhanced electrospinning (USES) as means to generate nanofibrous drug delivery systems (DDSs) for pharmaceutical and biomedical applications. Traditional electrospinning (TES) equipped with a conventional spinneret was used as a reference method. High-molecular polyethylene oxide (PEO) and chitosan
Arnout Mieremet et al.
PloS one, 12(3), e0174478-e0174478 (2017-03-24)
Full thickness human skin models (FTMs) contain an epidermal and a dermal equivalent. The latter is composed of a collagen dermal matrix which harbours fibroblasts. Current epidermal barrier properties of FTMs do not fully resemble that of native human skin
Mohammad Amin Shamekhi et al.
International journal of biological macromolecules, 127, 396-405 (2019-01-10)
Enhancement of physical and mechanical properties of the scaffolds is achieved via various methods including cross-linking and incorporation of nano particles. In the present research chitosan-based scaffolds firstly were reinforced with the incorporation of the graphene oxide (GO) nanoparticles. The
查看所有相关文献

全球贸易项目编号

货号GTIN
448877-250G04061835563135
448877-2KG04065274195964
448877-50G04061835563142